Predictors of retention in a drug-free unit/substance abuse treatment in prison

Casares-López, María José; Menéndez, Ana Gónzalez; Festinger, David S.; García, Paula Fernández; Fernández-Hermida, José Ramón; Secades, Roberto; Matejkowski, Jason

doi:10.1016/j.ijlp.2013.04.003

Cited by 10 publications

(7 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The high dropout rate to treatment was confirmed in a study developed with 227 drug addicts in a Psychosocial Care Center for Alcohol and Other Drugs (CAPS AD), in the state of Piaui, which presented 56.8% of non-completion of treatment (4) . This is also confirmed internationally, as a study in the region of Asturias, Spain, showed that among 57 chemical dependents undergoing treatment in a rehabilitation unit, the dropout rate was 52.9% in the period up to six months and 67.8% in a year (5) .…”

Section: Introductionsupporting

confidence: 56%

Motivações de dependentes químicos para o tratamento: percepção de familiares

et al. 2015

View full text Add to dashboard Cite

show abstract

Section: Introductionsupporting

confidence: 56%

Motivações de dependentes químicos para o tratamento: percepção de familiares

et al. 2015

View full text Add to dashboard Cite

show abstract

“…These significant changes in both quality of life and addiction severity were similar to the results described in a multisite clinical trial, which assessed Opioid Substitution Treatment (OST) in 13 treatment programs in seven low and middle income countries (24). The quality of life and addiction severity scales are important findings that are associated with improved retention (25).…”

Section: Discussionsupporting

confidence: 73%

Buprenorphine Added on Brief Cognitive Behavioral Therapy for Treatment of Methamphetamine Use Disorder

Shariatirad

Mahjoub

Haqiqi

et al. 2018

Iran J Psychiatry Behav Sci

View full text Add to dashboard Cite

Background: Methamphetamine (MA) use remains a major public health concern around the world. Recent findings suggest that buprenorphine may be helpful for cocaine use reduction. Moreover, animal studies described reduced dopamine peak effect following MA use, due to the administration of low dose buprenorphine. Objectives: This study examined the effectiveness of buprenorphine with brief cognitive behavioral therapy on MA use disorder. Methods: The study was conducted in an outpatient substance abuse treatment center in Qazvin, Iran. Nineteen MA users received buprenorphine for 24 weeks combined with brief cognitive behavioral therapy in an outpatient substance abuse treatment program, three times per week, as a before and after non -randomization study. Clinical outcomes included treatment retention, MA use, degree of MA dependency and craving, quality of life, cognitive abilities questionnaire, addiction severity and also adverse events. Data was analyzed by performing repeated measures analysis and the Friedman test for nonparametric variables. Results: Fifteen participants completed the study during six months and frequency of MA use was significantly decreased at 24 weeks (P < 0.001). There were also significant reductions in craving (P < 0.001), degree of MA dependence (P < 0.001), and improvements in quality of life, cognitive ability, and some subscales of addiction severity. Conclusions:The results of this preliminary clinical study demonstrated that buprenorphine could potentially attenuate MA craving and alternate rewarding effects of MA and had promising effects on cognitive impairment. Furthermore, buprenorphine can be considered as a harm reduction intervention in some communities, in which the people, as a result of cultural beliefs, do not accept a therapy, which only consists of counseling and no medications.

show abstract

“…11 Entrementes, outro estudo realizado na Espanha revelou que, entre 57 dependentes químicos em tratamento em uma unidade de reabilitação, 52,9% abandonaram o tratamento em um período de até seis meses. 12 Por sua magnitude, a não adesão ao tratamento constitui--se em um problema de saúde pública responsável por diversos prejuízos na vida do indivíduo e de seus familiares, os quais se relacionam ao agravamento do transtorno, desgaste familiar, internações evitáveis e aumento no custo dos cuidados de saúde. 13 Acredita-se que investigar essa temática favorece a reflexão e a reorientação da prática profissional na área da saúde, a partir da construção, produção e ampliação do conhecimento acerca dos fatores que interferem diretamente na adesão ao tratamento pelo dependente químico, com vistas ao aumento da adesão e da qualidade de vida dessa clientela.…”

Section: Introductionunclassified

Factors That Interfere in Patient Compliance With Chemical Dependence Treatment: Health Professionals’ Perceptions

Ferreira¹,

Borba²,

Capistrano³

et al. 2015

REME: Revista Mineira De Enfermagem

View full text Add to dashboard Cite

Pesquisa qualitativa e exploratória realizada de março a abril de 2013 em um centro de atenção psicossocial álcool e outras drogas da região metropolitana de Curitiba, com o objetivo de identificar a percepção dos profissionais de saúde sobre os fatores que interferem na adesão ao tratamento da dependência química. Participaram da pesquisa todos os profissionais de saúde. Os dados foram coletados mediante entrevista semiestruturada e analisados pela interpretação qualitativa de dados de Minayo, resultando em duas categorias: fatores intrínsecos ao dependente químico na adesão ao tratamento, que compreendeu influências de motivação, de uso de medicamentos e tipo de substância psicoativa; e fatores extrínsecos ao dependente químico na adesão ao tratamento, que englobou influências familiares, socioeconômicas e dos serviços de saúde. Concluiu-se que a identificação desses fatores ofertam subsídios para o planejamento de intervenções terapêuticas mais apropriadas, com vistas ao aumento da adesão e da qualidade de vida.

show abstract

Predictors of retention in a drug-free unit/substance abuse treatment in prison

Cited by 10 publications

References 49 publications

Motivações de dependentes químicos para o tratamento: percepção de familiares

Motivações de dependentes químicos para o tratamento: percepção de familiares

Buprenorphine Added on Brief Cognitive Behavioral Therapy for Treatment of Methamphetamine Use Disorder

Factors That Interfere in Patient Compliance With Chemical Dependence Treatment: Health Professionals’ Perceptions

Contact Info

Product

Resources

About